RxDoctor Payments Data

Joshua Metzl, MD

Foot and Ankle Surgery · Englewood, CONPI 1417116351

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,689,341 of the $1,847,729 with a category attached, or 91.4%. Arthrex accounts for 99.8% of it on its own, with 13 other manufacturers making up the rest. Among foot and ankle surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,847,729in general payments, 2019–2025

Across 267 payments — averaging $6920.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1.8M
  • Gemini Mountain Medical, LLC$2K
  • Stryker$522
  • Medline Industries LP$422
  • Treace Medical Concepts, Inc.$197
  • Biotissue Holdings Inc.$178
  • plus $604 from 8 others
$93,214in ownership & investment interests, 2019–2025

Across 3 payments — averaging $31,071 each. An ownership or investment interest held by the physician or an immediate family member.

  • GLW, Inc$93K

What the payments were for

  • Royalty or licence$1,689,34191%
  • Consulting fees$14,6131%
  • Speaking & faculty fees$129,2867%
  • Travel & lodging$8,5580%
  • Food & beverage$4,7300%
  • Education$1,2000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,847,729 in reported general payments places this provider in the 95th percentile of 181 foot and ankle surgery providers in Colorado.

See all foot and ankle surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$108,745
Medicare patients
385
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium16$145
Meloxicam21$125

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →